Global Oral Peptide Drugs Market Growth (Status and Outlook) 2026-2032

January 2026 | 71 pages | ID: G4C7A9407779EN
LP Information

Abstracts

The global Oral Peptide Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Peptide Drugs are usually composed of amino acid chains and can be linear or cyclic structures. Due to their large molecules, peptide drugs are usually administered by injection. Oral peptide drugs refer to peptide drugs that can be administered orally and play an important role in some diseases that require precise regulation of physiological processes.

United States market for Oral Peptide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Oral Peptide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Oral Peptide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Oral Peptide Drugs players cover Roche, Novartis, Aurinia, Merck & Co, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Oral Peptide Drugs Industry Forecast” looks at past sales and reviews total world Oral Peptide Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Peptide Drugs sales for 2026 through 2032. With Oral Peptide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Peptide Drugs industry.

This Insight Report provides a comprehensive analysis of the global Oral Peptide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Peptide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Peptide Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Peptide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Peptide Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Peptide Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cyclic Peptides
• Linear Peptides

Segmentation by Application:

• Tumors
• Kidney Disease
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Novartis
• Aurinia
• Merck & Co

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Peptide Drugs Market Size (2021-2032)
  2.1.2 Oral Peptide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oral Peptide Drugs by Country/Region (2021, 2025 & 2032)
2.2 Oral Peptide Drugs Segment by Type
  2.2.1 Cyclic Peptides
  2.2.2 Linear Peptides
  2.2.3 Oral Peptide Drugs Market Size by Type
    2.2.3.1 Oral Peptide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
2.3 Oral Peptide Drugs Segment by Application
  2.3.1 Tumors
  2.3.2 Kidney Disease
  2.3.3 Other
  2.3.4 Oral Peptide Drugs Market Size by Application
    2.3.4.1 Oral Peptide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Oral Peptide Drugs Market Size Market Share by Application (2021-2026)

3 ORAL PEPTIDE DRUGS MARKET SIZE BY PLAYER

3.1 Oral Peptide Drugs Market Size Market Share by Player
  3.1.1 Global Oral Peptide Drugs Revenue by Player (2021-2026)
  3.1.2 Global Oral Peptide Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Oral Peptide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL PEPTIDE DRUGS BY REGION

4.1 Oral Peptide Drugs Market Size by Region (2021-2026)
4.2 Global Oral Peptide Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Peptide Drugs Market Size Growth (2021-2026)
4.4 APAC Oral Peptide Drugs Market Size Growth (2021-2026)
4.5 Europe Oral Peptide Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral Peptide Drugs Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oral Peptide Drugs Market Size by Country (2021-2026)
5.2 Americas Oral Peptide Drugs Market Size by Type (2021-2026)
5.3 Americas Oral Peptide Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Peptide Drugs Market Size by Region (2021-2026)
6.2 APAC Oral Peptide Drugs Market Size by Type (2021-2026)
6.3 APAC Oral Peptide Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Peptide Drugs Market Size by Country (2021-2026)
7.2 Europe Oral Peptide Drugs Market Size by Type (2021-2026)
7.3 Europe Oral Peptide Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Peptide Drugs by Region (2021-2026)
8.2 Middle East & Africa Oral Peptide Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral Peptide Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL PEPTIDE DRUGS MARKET FORECAST

10.1 Global Oral Peptide Drugs Forecast by Region (2027-2032)
  10.1.1 Global Oral Peptide Drugs Forecast by Region (2027-2032)
  10.1.2 Americas Oral Peptide Drugs Forecast
  10.1.3 APAC Oral Peptide Drugs Forecast
  10.1.4 Europe Oral Peptide Drugs Forecast
  10.1.5 Middle East & Africa Oral Peptide Drugs Forecast
10.2 Americas Oral Peptide Drugs Forecast by Country (2027-2032)
  10.2.1 United States Market Oral Peptide Drugs Forecast
  10.2.2 Canada Market Oral Peptide Drugs Forecast
  10.2.3 Mexico Market Oral Peptide Drugs Forecast
  10.2.4 Brazil Market Oral Peptide Drugs Forecast
10.3 APAC Oral Peptide Drugs Forecast by Region (2027-2032)
  10.3.1 China Oral Peptide Drugs Market Forecast
  10.3.2 Japan Market Oral Peptide Drugs Forecast
  10.3.3 Korea Market Oral Peptide Drugs Forecast
  10.3.4 Southeast Asia Market Oral Peptide Drugs Forecast
  10.3.5 India Market Oral Peptide Drugs Forecast
  10.3.6 Australia Market Oral Peptide Drugs Forecast
10.4 Europe Oral Peptide Drugs Forecast by Country (2027-2032)
  10.4.1 Germany Market Oral Peptide Drugs Forecast
  10.4.2 France Market Oral Peptide Drugs Forecast
  10.4.3 UK Market Oral Peptide Drugs Forecast
  10.4.4 Italy Market Oral Peptide Drugs Forecast
  10.4.5 Russia Market Oral Peptide Drugs Forecast
10.5 Middle East & Africa Oral Peptide Drugs Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oral Peptide Drugs Forecast
  10.5.2 South Africa Market Oral Peptide Drugs Forecast
  10.5.3 Israel Market Oral Peptide Drugs Forecast
  10.5.4 Turkey Market Oral Peptide Drugs Forecast
10.6 Global Oral Peptide Drugs Forecast by Type (2027-2032)
10.7 Global Oral Peptide Drugs Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oral Peptide Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Oral Peptide Drugs Product Offered
  11.1.3 Roche Oral Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Oral Peptide Drugs Product Offered
  11.2.3 Novartis Oral Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Aurinia
  11.3.1 Aurinia Company Information
  11.3.2 Aurinia Oral Peptide Drugs Product Offered
  11.3.3 Aurinia Oral Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Aurinia Main Business Overview
  11.3.5 Aurinia Latest Developments
11.4 Merck & Co
  11.4.1 Merck & Co Company Information
  11.4.2 Merck & Co Oral Peptide Drugs Product Offered
  11.4.3 Merck & Co Oral Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Merck & Co Main Business Overview
  11.4.5 Merck & Co Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Peptide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral Peptide Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cyclic Peptides
Table 4. Major Players of Linear Peptides
Table 5. Oral Peptide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Oral Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
Table 8. Oral Peptide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Oral Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Oral Peptide Drugs Market Size Market Share by Application (2021-2026)
Table 11. Global Oral Peptide Drugs Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Oral Peptide Drugs Revenue Market Share by Player (2021-2026)
Table 13. Oral Peptide Drugs Key Players Head office and Products Offered
Table 14. Oral Peptide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oral Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Oral Peptide Drugs Market Size Market Share by Region (2021-2026)
Table 19. Global Oral Peptide Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Oral Peptide Drugs Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Oral Peptide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Oral Peptide Drugs Market Size Market Share by Country (2021-2026)
Table 23. Americas Oral Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
Table 25. Americas Oral Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Oral Peptide Drugs Market Size Market Share by Application (2021-2026)
Table 27. APAC Oral Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Oral Peptide Drugs Market Size Market Share by Region (2021-2026)
Table 29. APAC Oral Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Oral Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Oral Peptide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Oral Peptide Drugs Market Size Market Share by Country (2021-2026)
Table 33. Europe Oral Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Oral Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Oral Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Oral Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oral Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oral Peptide Drugs
Table 39. Key Market Challenges & Risks of Oral Peptide Drugs
Table 40. Key Industry Trends of Oral Peptide Drugs
Table 41. Global Oral Peptide Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Oral Peptide Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Oral Peptide Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Oral Peptide Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Roche Details, Company Type, Oral Peptide Drugs Area Served and Its Competitors
Table 46. Roche Oral Peptide Drugs Product Offered
Table 47. Roche Oral Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Novartis Details, Company Type, Oral Peptide Drugs Area Served and Its Competitors
Table 51. Novartis Oral Peptide Drugs Product Offered
Table 52. Novartis Oral Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Aurinia Details, Company Type, Oral Peptide Drugs Area Served and Its Competitors
Table 56. Aurinia Oral Peptide Drugs Product Offered
Table 57. Aurinia Oral Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Aurinia Main Business
Table 59. Aurinia Latest Developments
Table 60. Merck & Co Details, Company Type, Oral Peptide Drugs Area Served and Its Competitors
Table 61. Merck & Co Oral Peptide Drugs Product Offered
Table 62. Merck & Co Oral Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Merck & Co Main Business
Table 64. Merck & Co Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral Peptide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Peptide Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral Peptide Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral Peptide Drugs Sales Market Share by Country/Region (2025)
Figure 8. Oral Peptide Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral Peptide Drugs Market Size Market Share by Type in 2025
Figure 10. Oral Peptide Drugs in Tumors
Figure 11. Global Oral Peptide Drugs Market: Tumors (2021-2026) & ($ millions)
Figure 12. Oral Peptide Drugs in Kidney Disease
Figure 13. Global Oral Peptide Drugs Market: Kidney Disease (2021-2026) & ($ millions)
Figure 14. Oral Peptide Drugs in Other
Figure 15. Global Oral Peptide Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Oral Peptide Drugs Market Size Market Share by Application in 2025
Figure 17. Global Oral Peptide Drugs Revenue Market Share by Player in 2025
Figure 18. Global Oral Peptide Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Oral Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Oral Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Oral Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Oral Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Oral Peptide Drugs Value Market Share by Country in 2025
Figure 24. United States Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Oral Peptide Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Oral Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Oral Peptide Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Oral Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Oral Peptide Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Oral Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Oral Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Oral Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Oral Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Oral Peptide Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Oral Peptide Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Oral Peptide Drugs Market Size 2027-2032 ($ millions)